Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Pulse Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Pulse Biosciences, Inc. Earnings Date And Information
Pulse Biosciences, Inc. last posted its earnings results on Thursday, March 27th, 2025. The company reported $-0.17 earnings per share for the quarter, topping analysts' consensus estimates of $-0.24 by $0.07. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Pulse Biosciences, Inc. has generated $-1 earnings per share over the last year ($-0.92 diluted earnings per share) and currently has a price-to-earnings ratio of -18.98. Pulse Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based on prior year's report dates.
Pulse Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/28/2025 | Q4 2024 | N/A | -$0.32 | N/A | $0 | $0 |
| 10/30/2024 | Q3 2024 | -$0.24 | -$0.21 | 0.03 | $0 | $0 |
| 08/19/2024 | Q2 2024 | N/A | -$0.20 | N/A | $0 | $0 |
| 05/07/2024 | Q1 2024 | -$0.24 | -$0.18 | 0.06 | N/A | $0 |
| 03/28/2024 | Q4 2023 | -$0.24 | -$0.22 | 0.02 | N/A | $1.74 M |
| 11/13/2023 | Q3 2023 | -$0.24 | -$0.19 | 0.05 | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.22 | -$0.22 | 0 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.22 | -$0.27 | -0.05 | N/A | $0 |
| 03/31/2023 | Q4 2022 | N/A | -$0.25 | N/A | N/A | $-9,000 |
| 11/10/2022 | Q3 2022 | -$0.45 | -$0.49 | -0.04 | $200,000 | $0 |
| 08/10/2022 | Q2 2022 | -$0.37 | -$0.44 | -0.07 | $439,667 | $265,000 |
| 05/11/2022 | Q1 2022 | N/A | -$0.58 | N/A | $715,333 | $444,000 |
| 03/31/2022 | Q4 2021 | -$0.50 | -$0.52 | -0.02 | $872,000 | $844,000 |
| 11/15/2021 | Q3 2021 | -$0.54 | -$0.48 | 0.06 | $188,667 | $574,000 |
| 08/09/2021 | Q2 2021 | -$0.79 | -$0.58 | 0.21 | $34,133 | $0 |
| 05/10/2021 | Q1 2021 | -$0.52 | -$0.71 | -0.19 | N/A | $0 |
| 03/12/2021 | Q4 2020 | N/A | -$0.54 | N/A | N/A | $0 |
| 11/09/2020 | Q3 2020 | -$0.44 | -$0.51 | -0.07 | N/A | $0 |
| 08/10/2020 | Q2 2020 | -$0.50 | -$0.53 | -0.03 | N/A | $0 |
| 05/11/2020 | Q1 2020 | -$0.47 | -$0.57 | -0.1 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Pulse Biosciences, Inc. Earnings: FAQ's
Pulse Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based offlast year's report dates.
In the previous quarter, Pulse Biosciences, Inc. (:PLSE) reported $-0.17 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.24 by $0.07.
The conference call for Pulse Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Pulse Biosciences, Inc.'s latest earnings report can be read online.
Pulse Biosciences, Inc. (:PLSE) has a recorded net income of $-53,585,000.Pulse Biosciences, Inc. has generated $-0.92 earnings per share over the last four quarters.
Pulse Biosciences, Inc. (:PLSE) has a price-to-earnings ratio of -18.98 and price/earnings-to-growth ratio is 1.54.